180 Degree Capital Corp. is part of the asset management industry and trades as part of the financial services sector. The company CEO is Kevin Rendino. 180 Degree Capital Corp is a non-diversified management investment company operating as a business development company. It invests in companies commercializing and integrating products enabled by disruptive technologies in the life sciences.
Previous Intraday Performance:
The TURN shares had a previous change of 3.47% which opened at 1.87 and closed at 1.94. It moved to an intraday high of 1.95 and a low of 1.87.
Over the last five trading days, TURN shares returned 2.65% and in the past 30 trading days it returned 0.00%. Over three months, it changed 1.28%. In one year it has changed -1.02% and within that year its
52-week high was 2.50 and its 52-week low was 1.72. TURN stock is 12.79% above its 52 Week Low.
Our calculations result in a 200 day moving average of 2.10 and a 50 day moving average of 1.93. Right now, TURN stock is trading -7.51% below its 200 day moving average and may not be a great opportunity to buy as it may continue to trend down.
The company has a market cap of $60.4m with 31.1m shares outstanding and a float of 28.8m shares. Trading volume was 70,979 shares and has experienced an average volume of 60,652 shares. Our calculation, using the current average volume and close price, leads me to believe that the liquidity is bad, highly speculative and an investor may want to avoid this stock.
The last annual reported EPS for 180 Degree Capital Corp. was 0.04 which ended on 31st of December 2018, which according to the previous close, that is a PE of 48.50.
Below was the last reported quarterly earnings per share:
12-31-2018: 0.00 (estimated)
The next earnings report will be: 03-21-2019
EPS growth is an important number as it indicates the future prospects of 180 Degree Capital Corp.; it is typically displayed as a percentage and called the EPS growth rate, which at this time is hard to estimate, but revenue growth has been -70.70% over the last twelve months.
Indicators Also to Watch:
Based on the latest filings, there is 7.50% of insider ownership and 29.70% of institutional ownership.
I calculated the beta to be -75.77
SeekingAlpha: VBI Vaccines reports FY results
Based on last reported financials, the company’s return on equity is 1.22%, return on assets is 1.18%, profit margin is 23.68%, price-to-sales is 13.93 and price-to-book is 0.71.
Company Score Card:
Results are out of six:
5 : Growth Expectations Result
6 : Financial Safety Result
0 : Past Performance Result
1 : Valuation Result
0 : Dividend Safety Result
3 : Overall Result